Abametapir Patent Expiration
Abametapir is Used for treating head lice infestation in patients 6 months of age and older. It was first introduced by Hatchtech Pty Ltd
Abametapir Patents
Given below is the list of patents protecting Abametapir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xeglyze | US10292389 | Pediculicidal composition | Dec 17, 2034 | Hatchtech |
| Xeglyze | US7812163 | Methods and compositions for controlling ectoparasites | Oct 28, 2026 | Hatchtech |
| Xeglyze | US8212038 | Methods and compositions for controlling ectoparasites |
Jul 16, 2024
(Expired) | Hatchtech |
| Xeglyze | US9357783 | Methods and compositions for controlling ectoparasites |
Jul 16, 2024
(Expired) | Hatchtech |
| Xeglyze | US9839631 | Methods and compositions for controlling ectoparasites |
Jul 16, 2024
(Expired) | Hatchtech |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Abametapir's patents.
Latest Legal Activities on Abametapir's Patents
Given below is the list recent legal activities going on the following patents of Abametapir.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical | 03 May, 2024 | US8212038 |
| Change in Power of Attorney (May Include Associate POA) Critical | 03 May, 2024 | US9357783 |
| Email Notification Critical | 03 May, 2024 | US9839631 |
| Email Notification Critical | 03 May, 2024 | US9357783 |
| Change in Power of Attorney (May Include Associate POA) Critical | 03 May, 2024 | US8212038 |
| Email Notification Critical | 03 May, 2024 | US7812163 |
| Change in Power of Attorney (May Include Associate POA) Critical | 03 May, 2024 | US7812163 |
| Change in Power of Attorney (May Include Associate POA) Critical | 03 May, 2024 | US9839631 |
| Email Notification Critical | 18 Apr, 2024 | US10292389 |
| Change in Power of Attorney (May Include Associate POA) Critical | 18 Apr, 2024 | US10292389 |
Abametapir's Family Patents
